Home Cart 0 Sign in  

[ CAS No. 619-08-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 619-08-9
Chemical Structure| 619-08-9
Structure of 619-08-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 619-08-9 ]

Related Doc. of [ 619-08-9 ]

Alternatived Products of [ 619-08-9 ]

Product Details of [ 619-08-9 ]

CAS No. :619-08-9 MDL No. :MFCD00043910
Formula : C6H4ClNO3 Boiling Point : -
Linear Structure Formula :- InChI Key :BOFRXDMCQRTGII-UHFFFAOYSA-N
M.W : 173.55 Pubchem ID :12074
Synonyms :

Calculated chemistry of [ 619-08-9 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 42.3
TPSA : 66.05 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.75 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.35
Log Po/w (XLOGP3) : 2.26
Log Po/w (WLOGP) : 1.95
Log Po/w (MLOGP) : 0.88
Log Po/w (SILICOS-IT) : -0.13
Consensus Log Po/w : 1.26

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.68
Solubility : 0.365 mg/ml ; 0.0021 mol/l
Class : Soluble
Log S (Ali) : -3.28
Solubility : 0.0904 mg/ml ; 0.000521 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.81
Solubility : 2.66 mg/ml ; 0.0153 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.7

Safety of [ 619-08-9 ]

Signal Word:Danger Class:9
Precautionary Statements:P261-P264-P270-P272-P273-P280-P301+P312+P330-P302+P352-P305+P351+P338+P310-P333+P313-P391-P501 UN#:3077
Hazard Statements:H302-H315-H317-H318-H410 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 619-08-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 619-08-9 ]
  • Downstream synthetic route of [ 619-08-9 ]

[ 619-08-9 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 4920-79-0 ]
  • [ 18093-12-4 ]
  • [ 619-08-9 ]
  • [ 636-93-1 ]
Reference: [1] Journal of Organic Chemistry, 2013, vol. 78, # 10, p. 4834 - 4839
[2] Journal of Organic Chemistry, 2008, vol. 73, # 5, p. 1925 - 1934
  • 2
  • [ 619-08-9 ]
  • [ 77-78-1 ]
  • [ 4920-79-0 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 27, p. 4883 - 4886
[2] Journal of the Chemical Society, 1930, p. 2166,2168
  • 3
  • [ 619-08-9 ]
  • [ 74-88-4 ]
  • [ 4920-79-0 ]
Reference: [1] Journal of Organic Chemistry, 1996, vol. 61, # 4, p. 1551 - 1554
[2] Bulletin of the Chemical Society of Japan, 1994, vol. 67, # 10, p. 2639 - 2646
  • 4
  • [ 95-57-8 ]
  • [ 619-08-9 ]
  • [ 603-86-1 ]
YieldReaction ConditionsOperation in experiment
92% With silica supported Al(NO3)3*9H2O In acetone at 20℃; for 0.416667 h; General procedure: To a solution of phenol (1 mmol) in acetone (5 mL) wasadded silica supported Al(NO3)3·9H2O (1 mmol) and theresulting mixture stirred at room temperature. After completionof the reaction, as indicated by TLC, the reaction masswas filtered and the residue (silica) was washed with ethylacetate (2 5 mL). The filtrate and the washing were collectivelyconcentrated under reduced pressure, and the crudecompound was purified by column chromatography oversilica gel (100-200 mesh) to afford the pure ortho-nitro phenol(95percent) and para- nitro phenol (3percent).
36% With nickel(II) nitrate hexahydrate In tetrahydrofuran at 50℃; for 4 h; General procedure: A suspension of 2-methylphenol(18.5 mmol, 1.0 eq) and Cu(NO3)2.3H2O (27.7 mmol, 1.5 eq) in THF was stirred magnetically at 60°C or reflux for several hours. Then after the solvent was removed under vacuum, the mixture was extracted with EtOAc (3×30 mL). The combined organic layers were washed with brine (5mL), dried over anhydrous MgSO4 and concentrated under vacuum. The crude residue was purified by column chromatography to afford the product (67-90percent).
Reference: [1] Letters in Organic Chemistry, 2015, vol. 12, # 2, p. 129 - 135
[2] Bulletin de la Societe Chimique de France, 1996, vol. 133, # 10, p. 973 - 977
[3] International Journal of Chemical Kinetics, 2016, vol. 48, # 4, p. 171 - 196
[4] Synthetic Communications, 2003, vol. 33, # 6, p. 961 - 966
[5] European Journal of Organic Chemistry, 2005, # 11, p. 2379 - 2384
[6] Tetrahedron, 1989, vol. 45, # 5, p. 1415 - 1422
[7] Tetrahedron, 2005, vol. 61, # 46, p. 10861 - 10867
[8] Tetrahedron, 2005, vol. 61, # 46, p. 10861 - 10867
[9] Bulletin de la Societe Chimique de France, 1996, vol. 133, # 10, p. 973 - 977
[10] Bulletin de la Societe Chimique de France, 1996, vol. 133, # 10, p. 973 - 977
[11] Journal of Organic Chemistry, 2005, vol. 70, # 22, p. 9071 - 9073
[12] Arkivoc, 2014, vol. 2014, # 5, p. 64 - 71
[13] Journal of the American Chemical Society, 1982, vol. 104, # 23, p. 6470 - 6471
[14] Roczniki Chemii, 1930, vol. 10, p. 761,765,771[15] Chem. Zentralbl., 1931, vol. 102, # I, p. 1427
[16] Chemische Berichte, 1872, vol. 5, p. 778[17] Justus Liebigs Annalen der Chemie, 1874, vol. 173, p. 306
[18] Tetrahedron, 1989, vol. 45, # 5, p. 1299 - 1310
[19] Journal of the American Chemical Society, 1934, vol. 56, p. 1787,1790
[20] Quarterly Journal of Pharmacy and Pharmacology, 1945, vol. 18, p. 41,43
[21] Journal of the American Chemical Society, 1934, vol. 56, p. 1787,1790
[22] Quarterly Journal of Pharmacy and Pharmacology, 1945, vol. 18, p. 41,43
[23] Chemische Berichte, 1872, vol. 5, p. 778[24] Justus Liebigs Annalen der Chemie, 1874, vol. 173, p. 306
[25] Tetrahedron, 1989, vol. 45, # 5, p. 1299 - 1310
[26] South African Journal of Chemistry, 2006, vol. 59, p. 93 - 96
[27] Synthetic Communications, 2013, vol. 43, # 19, p. 2672 - 2677
  • 5
  • [ 121-73-3 ]
  • [ 619-08-9 ]
  • [ 89-64-5 ]
  • [ 603-86-1 ]
Reference: [1] Journal of Organic Chemistry, 1990, vol. 55, # 17, p. 4979 - 4981
[2] Journal of Organic Chemistry USSR (English Translation), 1986, vol. 22, p. 720 - 726[3] Zhurnal Organicheskoi Khimii, 1986, vol. 22, # 4, p. 806 - 814
[4] Journal of Organic Chemistry, 1998, vol. 63, # 13, p. 4199 - 4208
  • 6
  • [ 88-75-5 ]
  • [ 619-08-9 ]
  • [ 603-86-1 ]
Reference: [1] Roczniki Chemii, 1930, vol. 10, p. 761,765,771[2] Chem. Zentralbl., 1931, vol. 102, # I, p. 1427
  • 7
  • [ 121-73-3 ]
  • [ 619-08-9 ]
  • [ 89-64-5 ]
  • [ 603-86-1 ]
  • [ 139-24-2 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1986, vol. 22, p. 720 - 726[2] Zhurnal Organicheskoi Khimii, 1986, vol. 22, # 4, p. 806 - 814
  • 8
  • [ 95-57-8 ]
  • [ 7697-37-2 ]
  • [ 619-08-9 ]
  • [ 603-86-1 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1874, vol. 173, p. 303
  • 9
  • [ 99-54-7 ]
  • [ 619-08-9 ]
  • [ 39224-65-2 ]
  • [ 28165-60-8 ]
Reference: [1] Journal of Organic Chemistry, 1998, vol. 63, # 13, p. 4199 - 4208
  • 10
  • [ 619-08-9 ]
  • [ 3964-52-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 22, p. 5864 - 5869
[2] Molecular crystals and liquid crystals, 1982, vol. 80, # 1-4, p. 105 - 118
[3] Journal of the American Chemical Society, 1923, vol. 45, p. 2191,2193
[4] Journal of the American Chemical Society, 1923, vol. 45, p. 2191,2193
[5] Chemische Berichte, 1925, vol. 58, p. 664
[6] Quarterly Journal of Pharmacy and Pharmacology, 1945, vol. 18, p. 41,43
[7] Justus Liebigs Annalen der Chemie, 1886, vol. 234, p. 3
[8] Zeitschrift fuer Chemie, 1871, p. 339
[9] Inorganic Chemistry, 2014, vol. 53, # 11, p. 5692 - 5697
[10] RSC Advances, 2015, vol. 5, # 16, p. 11913 - 11916
[11] Journal of the Brazilian Chemical Society, 2016, vol. 27, # 2, p. 372 - 381
[12] ACS Catalysis, 2016, vol. 6, # 7, p. 4110 - 4116
[13] RSC Advances, 2016, vol. 6, # 98, p. 96431 - 96435
[14] Langmuir, 2018, vol. 34, # 46, p. 13897 - 13904
  • 11
  • [ 619-08-9 ]
  • [ 3964-52-1 ]
Reference: [1] Patent: US5866611, 1999, A,
  • 12
  • [ 619-08-9 ]
  • [ 30880-72-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1970, vol. 13, p. 1165 - 1170
  • 13
  • [ 619-08-9 ]
  • [ 202197-26-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 17, p. 4686 - 4691
[2] European Journal of Medicinal Chemistry, 2015, vol. 94, p. 175 - 194
[3] Journal of Medicinal Chemistry, 2015, vol. 58, # 14, p. 5522 - 5537
[4] Patent: US2015/366868, 2015, A1,
[5] Archiv der Pharmazie, 2016, vol. 349, # 11, p. 827 - 847
[6] Patent: CN103483324, 2016, B,
[7] European Journal of Medicinal Chemistry, 2018, vol. 144, p. 330 - 348
[8] Patent: CN105085496, 2018, B,
[9] Patent: US2016/214964, 2016, A1,
[10] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 316 - 336
[11] Patent: US2018/208584, 2018, A1,
[12] Patent: WO2006/55268, 2006, A2,
  • 14
  • [ 619-08-9 ]
  • [ 524955-09-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 11, p. 3090 - 3104
[2] Research on Chemical Intermediates, 2013, vol. 39, # 7, p. 3105 - 3110
[3] European Journal of Medicinal Chemistry, 2018, vol. 144, p. 330 - 348
[4] Patent: US2016/214964, 2016, A1,
[5] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 316 - 336
  • 15
  • [ 619-08-9 ]
  • [ 6959-47-3 ]
  • [ 524955-09-7 ]
Reference: [1] Patent: EP3181553, 2017, A1,
[2] Patent: WO2006/55268, 2006, A2,
  • 16
  • [ 619-08-9 ]
  • [ 456-41-7 ]
  • [ 443882-99-3 ]
YieldReaction ConditionsOperation in experiment
99% With potassium carbonate In acetone at 30℃; for 16 h; A mixture of 2-chloro-4-nitrophenol (35 g, 0.2 mol), m-furobenzylbromide (45.4 g, 0.24 mol), K2CO3 (55.2 g, 0.4 mol) and acetone (800 mL) was stirred at 30 0C for 16h. The resulting mixture was filtered and washed with acetone. The filtrate was concentrated to give the crude product which was washed with petroleum ether and dried to give the product 1502 as a yellow solid (55.0 g, 99percent yield). 1H NMR (DMSO-J6): δ 8.33 (d, J = 3.3 Hz, IH), 8.21-8.26 (m, IH), 7.42-7.50 (m, 2H), 7.29- 7.33 (m, 2H), 7.16-7.22 (m, IH), 5.39 (s, 2H). LC-MS: 282 (M+l).
95% With potassium carbonate In acetonitrile (c)
4-(3-fluorobenzyloxy)-3-chloro Nitrobenzene
2-chloro-4-nitrophenol (9.02 g, 52 mmol)), 3-fluorobenzyl bromide (9.85 g, 52 mmol) and acetonitrile (90 mL) was combined at room temperature under nitrogen.
Potassium carbonate (7.9 g, 57 mmol)) was added and the reaction mixture stirred at 60° C. for 2 hours and then cooled to room temperature.
After cooling the reaction mixture was poured into water.
The solids were collected by filtration and washed with diethyl ether to afford the desired product (13.98 g, 95percent yield).
[TLC system=1:1 EtOAc:Hexanes, Rf=0.76]
95% With potassium carbonate In acetonitrile at 20 - 60℃; for 2 h; Inert atmosphere 2-chloro-4-nitrophenol (9.02 g, 52 mmol)), 3-fluorobenzyl bromide (9.85 g, 52 mmol) and acetonitrile (90 mL) was combined at room temperature under nitrogen.
Potassium carbonate (7.9 g, 57 mmol)) was added and the reaction mixture stirred at 60° C. for 2 hours and then cooled to room temperature.
After cooling the reaction mixture was poured into water.
The solids were collected by filtration and washed with diethyl ether to afford the desired product (13.98 g, 95percent yield).
[TLC system=1:1 EtOAc:Hexanes, Rf=0.76]
95%
Stage #1: With potassium carbonate In acetonitrile at 20℃; for 0.5 h;
Stage #2: Reflux
Compound 1 was weighed 100g in 2L three-necked flask, mechanical stirring, 1000mLCH3CN 76gK2CO3Reacting at room temperature, after half an hour the reaction was slowly added dropwise 104g of compound 2. After the addition, the reaction was heated at reflux for 4 hours.After the reaction was cooled to room temperature, the reaction flask was added a lot of water, stirred, suction filtered, washed with ethanol and a small amount of solid, Compound 3, quality 134g, 95percent yield
95% With potassium carbonate In acetonitrile at 60℃; for 2 h; Inert atmosphere 2-Chloro-4-nitrophenol (9.02 g, 52 mmol), 3-fluorobenzyl bromide (9.85 g, 52 mmol)90 ml of acetonitrile was added to the reaction flask while potassium carbonate (7.0 g, 57 mmol) was addedThe reaction was added to it under a nitrogen atmosphere at 60°C for two hours and then the reaction was allowed to come to room temperature.Pour 80 ml of water into the reaction flask and filter under reduced pressure to obtain a solid.The filter cake was washed twice with ethyl acetate (50 ml x 2) to give a final solid product (13.16 g, yield 95percent).
94% With potassium carbonate In acetonitrile at 70℃; for 18 h; Step 8; Preparation of 3-chloro-4-f3-fluoro-benzvloxv)-phenvlamine; To 90 mL CH3CN was added 2-chloro-4-nitrophenol (15 g, 86.4 mmol) followed by potassium carbonate (17.9 g, 129.6 mmol). To the stirring suspension was added via dropping funnel a 10 mL CH3CN solution of 3-fluoro-benzylbromide(16.3 g, 86.4 mmol). The contents were stirred and heated at 70°C for 18 h, after which time the bright yellow mixture was allowed to cool to it. The yellow contents were poured onto water (200 mL) and stirred, upon which solid formation occurs. The solid was filtered and filter cake washed with additional water (50 mL). The collected solid was dried in vacuo, yielding 2-chloro-1-(3-fluoro-benzoyloxy)-4- nitro-benzene (23 g, 94percent) as a white solid.2-Chloro-1-(3-fluoro-benzoyloxy)-4-nitro-benzene (10 g, 35.5 mmol) was suspended in 50 mL acetic acid and 150 mL EtOAc in a 500 mL flask. Iron (9.9 g (177.5 mmol) was added to this suspension, and the mixture stirred at rt overnight. The reaction mixture was filtered through a thin pad of Celite.(R).. The filtrate was concentrated in vacuo and neutralized with saturated Na2CO3 aq solution, followed by EtOAc extraction. The organic layer was washed with brine, dried over Na2SO4, and concentrated in vacuo. The resulting crude material was purified by flash chromatography eluting with 15percent EtOAc/hexanes yielding 3-chloro-4-(3-fluoro- benzyloxy)-phenylamine as a brown solid [8.5 g, 95percent, TLC Rf = 0.4, 30percentEtOAc/Hex.(3:7)]. 1H-NMR (DMSO-d6) δ 4.94 (s, 2H), 5.00 (s, 2H), 6.40 (dd, 1H), 6.60 (s, 1H), 6.87 (d, 1H), 7.10-7.18 (m, 1H), 7.20-7.28 (m, 2H), 7.37-7.44 (m, 1H).
94% With potassium carbonate In acetonitrile at 70℃; for 18 h; To 90 mL CH3CN was added 2-chloro-4-nitrophenol (15 g, 86.4 mmol) followed by potassium carbonate (17.9 g, 129.6 mmol). To the stirring suspension was added via EPO <DP n="33"/>dropping funnel a 10 niL CH3CN solution of 3-fluoro-benzylbromide (16.3 g, 86.4 mmol). The contents were stirred and heated at 70 0C for 18 h, after which time the bright yellow mixture was allowed to cool to rt. The yellow contents were poured onto H2O (200 mL) and stirred, upon which solid formation occurs. The solid was filtered and filter cake washed with additional H2O (50 mL). The collected solid was dried in vacuo, yielding 2- chloro-l-(3-fluoro~benzoyloxy)-4-nitro-benzene (23 g, 94percent) as a white solid.
87.5% With potassium carbonate In acetone at 30℃; for 12 h; A mixture of 2-chloro-4-nitrophenol (2.00 g, 11.6 mmol), m-fluorobenzylbromide (2.60 g, 13.8 mmol), K2CO3 (3.19 g, 23.1 mmol) and acetone (50 mL) was stirred at 30° C. for 12 hours.
The resulting mixture was filtered and washed with acetone.
The filtrate was concentrated to give the crude product which was washed with petroleum ether and dried to produce the product as a yellow solid (2.80 g, yield 87.5percent).
1H-NMR (300 MHz, DMSO-d6): δ 8.35 (d, J=2.8 Hz, 1H), 8.25 (dd, J1=9.6 Hz, J2=2.8 Hz, 1H), 7.49-7.45 (m, 2H), 7.31-7.34 (m, 2H), 7.20-7.21 (m, 1H), 3.32 (s, 2H)
87.5% With potassium carbonate In acetone at 30℃; for 12 h; A mixture of 2-chloro-4-nitrophenol (2.00 g, 11.6 mmol), m-fluorobenzylbromide (2.60 g, 13.8 mmol), K2CO3 (3.19 g, 23.1 mmol) and acetone (50 mL) was stirred at 30° C. for 12 hours.
The resulting mixture was filtered and washed with acetone.
The filtrate was concentrated to give the crude product which was washed with petroleum ether and dried to produce the product as a yellow solid (2.80 g, yield 87.5percent).
1H-NMR (300 MHz, DMSO-d6): δ 8.35 (d, J=2.8 Hz, 1H), 8.25 (dd, J1=9.6 Hz, J2=2.8 Hz, 1H), 7.49-7.45 (m, 2H), 7.31-7.34 (m, 2H), 7.20-7.21 (m, 1H), 3.32 (s, 2H); MS (ES) m/e 280 [M-H]+.

Reference: [1] Patent: WO2008/33747, 2008, A2, . Location in patent: Page/Page column 172
[2] Journal of Medicinal Chemistry, 2015, vol. 58, # 14, p. 5522 - 5537
[3] Patent: US2004/53946, 2004, A1,
[4] Patent: US2015/366868, 2015, A1, . Location in patent: Paragraph 0157
[5] Patent: CN103483324, 2016, B, . Location in patent: Paragraph 0040; 0050-0051
[6] Patent: CN105085496, 2018, B, . Location in patent: Paragraph 0040; 0041
[7] Patent: WO2006/44524, 2006, A1, . Location in patent: Page/Page column 50
[8] Patent: WO2006/55268, 2006, A2, . Location in patent: Page/Page column 31; 32
[9] Patent: US2018/208564, 2018, A1, . Location in patent: Paragraph 0348-0349
[10] Patent: US2018/208584, 2018, A1, . Location in patent: Paragraph 0285; 0286
[11] Patent: US2003/232883, 2003, A1,
[12] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 17, p. 4686 - 4691
[13] Patent: EP1990337, 2008, A1, . Location in patent: Page/Page column 6-7
[14] Patent: EP2116540, 2009, A1, . Location in patent: Page/Page column 6
[15] Patent: US2008/300248, 2008, A1, . Location in patent: Page/Page column 4
[16] Patent: US2010/168142, 2010, A1, . Location in patent: Page/Page column 4
[17] Archiv der Pharmazie, 2016, vol. 349, # 11, p. 827 - 847
  • 17
  • [ 619-08-9 ]
  • [ 456-42-8 ]
  • [ 443882-99-3 ]
YieldReaction ConditionsOperation in experiment
57% With potassium carbonate In acetonitrileReflux Step 1:
2-chloro-1-(3-fluorobenzyloxy)-4-nitrobenzene
2-chloro-4-nitrophenol (3.4 g, 20 mmol), 3-fluorobenzyl chloride (2.8 g, 20 mmol) and potassium carbonate (3.3 g, 24 mmol) was refluxed in acetonitrile (30 mL) overnight.
The reaction mixture was poured into 100 mL of H2O, extracted with ethyl acetate.
The organic phase was washed with saturated brine, dried, concentrated in vacuo to obtain the crude product.
The crude product was washed with petroleum ether, filtered and dried, and the compound shown in the title (3.2 g, 57percent) was obtained.
1H NMR (CDCl3): δ 8.35 (1H, d, J=2.8 Hz), 8.17-8.14 (1H, m), 7.44-7.38 (1H, m), 7.25-7.19 (2H, m), 7.10-7.06 (1H, m), 7.03 (1H, d, J=9.2 Hz), 5.26 (2H, s).
53% With potassium carbonate In N,N-dimethyl-formamide at 75℃; for 23 h; Inert atmosphere The synthesis was performed as described by Shiao et al. for similar compounds [60]. The work-up was performed as described by Fontana et al. [61]. 2-Chloro-4-nitrophenol (1.50 g, 8.64 mmol) was mixed with K2CO3 (3.58 g, 25.9 mmol), before DMF (90 mL) was added under nitrogen atmosphere. The mixture was heated to 75 °C, and 3-fluorobenzyl chloride (1.87 g, 13.0 mmol) dissolved in DMF (60 mL) was added slowly. The reaction mixture was stirred at 75 °C for 23 h, cooled to rt, quenched into cold water (150 mL, 5 °C) and filtered. The isolated solid was washed with an ACN/water mixture (1/1, 50 mL), and n-hexane (30 mL). The obtained white solid was dried under reduced pressure. This yielded 1.29 g (4.58 mmol, 53percent) of 2-chloro-1-((3-fluorobenzyl)oxy)-4-nitrobenzene as a white solid, mp. 90–96 °C; 1H NMR (400 MHz, DMSO-d6) δ: 8.35 (d, J=2.8, 1H), 8.25 (dd, J=8.8, 2.8, 1H), 7.52–7.44 (m, 2H), 7.35–7.30 (m, 2H), 7.24–7.17 (m, 1H), 5.42 (s, 2H); 13C NMR (100 MHz, DMSO-d6) δ: 162.2 (d, J=243.7), 158.6, 140.9, 138.4 (d, J=8.1), 130.7 (d, J=8.1), 125.4, 124.6, 123.5 (d, J=2.9), 122.0, 115.1 (d, J=20.6), 114.3 (d, J=22.0), 113.8, 70.1 (d, J=2.1); 19F NMR (564 MHz, DMSO-d6, C6F6) δ: −115.15 (s, dec.); 1H NMR findings are in accordance with literature [59].
Reference: [1] Patent: US2016/214964, 2016, A1, . Location in patent: Paragraph 0124
[2] European Journal of Medicinal Chemistry, 2015, vol. 94, p. 175 - 194
[3] Patent: EP3181553, 2017, A1, . Location in patent: Paragraph 0198; 0199
[4] European Journal of Medicinal Chemistry, 2018, vol. 144, p. 330 - 348
[5] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 316 - 336
  • 18
  • [ 619-08-9 ]
  • [ 456-47-3 ]
  • [ 443882-99-3 ]
YieldReaction ConditionsOperation in experiment
93% With tributylphosphine; diamide In tetrahydrofuran at 10 - 40℃; for 1.5 h; To a 1000 ml reaction flask was added 350 ml of tetrahydrofuran, 75 g of 2-chloro-4-nitrophenol, 58.0 g 3-fluorobenzyl alcoholAnd 106gTributylphosphine,Turn agitated, cool to 10 ° C, slowly drop 90 g of tetramethylazodicarbonamide (TMAD) and 200 mlTetrahydrofuran, the solution was added dropwise and the temperature was stirred at 10 ° C for 1.5 hours. The reaction was carried out at a temperature of 40 ° CThe reaction solution was concentrated under reduced pressure to dryness, and the residue was stirred with N, N-dimethylformamide (200 ml), and the mixture was cooled to 0 ° C.The resulting solid was dried at 55-60 ° C to give 113.2 g of a pale yellow solid, 99.82percent purity and a yield of 93.0percent.
Reference: [1] Patent: CN106543007, 2017, A, . Location in patent: Paragraph 0017; 0018; 0019; 0020; 0021; 0022
  • 19
  • [ 619-08-9 ]
  • [ 848139-78-6 ]
Reference: [1] Research on Chemical Intermediates, 2013, vol. 39, # 7, p. 3105 - 3110
  • 20
  • [ 619-08-9 ]
  • [ 6959-47-3 ]
  • [ 179687-79-7 ]
YieldReaction ConditionsOperation in experiment
98%
Stage #1: With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5 h;
Stage #2: With potassium iodide In N,N-dimethyl-formamide at 60℃; for 12 h;
2-(Chloromethyl)pyridine hydrochloride (16.4 g, 0.1 mol) and K2CO3 (27.6 g, 0.2 mol) were suspended in DMF (100 mL) and stirred at room temperature for 30 min. 2-Chloro-4-nitrophenol (17.4 g, 0.1 mol) and KI (0.83 g, 5 mol percent) were added in and the reaction mixture was stirred at 60 °C for 12 h. The reaction suspension was diluted with water (400 mL) and the resulting solid was filtered, washed with water and dried to give 2-((2-chloro-4-nitrophenoxy)methyl)pyridine (26 g, 98percent) as a white solid. Mp 149.2–149.9 °C; MS-EI (m/z): 92, 229, 263(M+).
74% With potassium carbonate; sodium iodide In acetonitrileReflux Step 1:
2-((2-chloro-4-nitrophenoxy)methyl)pyridine
2-chloro-4-nitrophenol (3.4 g, 20 mmol), 2-(chloromethyl)pyridine hydrochloride (3.4 g, 21 mmol), potassium carbonate (3.3 g, 24 mmol) and sodium iodide (3.0 g, 20 mmol) were refluxed in acetonitrile (30 mL) overnight.
The reaction mixture was poured into 100 mL of H2O, extracted with ethyl acetate.
The organic phase was washed with saturated brine, dried, evaporated with rotary evaporator, to obtain the crude product.
The crude product was washed with petroleum ether, filtered and dried, and the compound shown in the title (3.9 g, 74percent) was obtained.
1H NMR (CDCl3): δ 8.63 (1H, d, J=4.8 Hz), 8.34 (1H, d, J=2.8 Hz), 8.16-8.14 (1H, m), 7.79-7.76 (1H, m), 7.62-7.60 (1H, m), 7.31-7.27 (1H, m), 7.11 (1H, d, J=9.2 Hz), 5.49 (2H, s).
52% With caesium carbonate; sodium iodide In acetonitrile at 60℃; for 5 h; 2-CHLORO-4-NITRO PHENOL 10G (57.6 MMOL, 1EQ), 2-PYCOLYL CHLORIDE hydrogen chloride 9.45g (57.6 mmol, 1 eq) cesium carbonate 41.3 (126.8 mmol, 2.2 eq) and sodium iodide 8. 64G (57.6 mmol, 1 eq) were suspended in 200 mL acetonitrile. The reaction mixture was stirred at 60°C for 5h. The resulted suspension was filtered and washed with 400 mL water, YIELDING 2- (2-CHLORO-4-NITRO-PHENOXYMETHYL)-PYRIDINE (8G, 52percent) as a red solid. 2- (2-CHLORO-4-NITRO-PHENOXYMETHYL)-PYRIDINE (8 g, 30. 2MMOL, 1 eq) and 8. 44g iron (151.1 mmol, 5 eq) were mixed in 100 mL acetic acid and 50 mL ethyl acetate and were stirred at rt overnight. The reaction mixture was filtered through celite pad. The filtrate was concentrated in vacuo and neutralized with sat. NA2CO3 solution. The solution was extracted with ethyl acetate and the organic layer was washed with brine and concentrated in vacuo. The resulting crude material was purified by flash chromatography eluting with 30percent ethyl acetate/hexane yielding 3. 2G of 3-Chloro-4- (pyridin-2-ylmethoxy)-phenylamine as a white solid (52percent). 1H-NMR (CDCL3) No. 5.18 (s, 2H), 6.50 (dd, 1H), 6.76 (d, 1H),. 6.80 (d, 1H), 7.22 (m, 1 H), 7.64 (d, 1H), 7.73 (td, 1H), 8.55 (m, 1H) ; LCMS RT = 0.89 min; [M+H]+= 235.1.
52% With caesium carbonate; sodium iodide In acetonitrile at 60℃; for 5 h; 2-chloro-4-nitro phenol 1Og (57.6 mmol, leq), 2-pycolyl chloride hydrogen chloride 9.45g (57.6 mmol, 1 equiv) cesium carbonate 41.3 (126.8 mmol, 2.2 equiv) and sodium iodide 8.64g (57.6 mmol, 1 equiv) were suspended in 200 mL acetonitrile. The reaction mixture was stirred at 60°C for 5h. The resulted suspension was filtered and washed with 400 mL water, yielding 2-(2-chloro-4-nitro-phenoxymethyl)-pyridine (8g, 52percent) as a red solid. 2-(2-chloro-4-nitro-phenoxymethyl)-pyridine (8 g, 30.2mmol, 1 equiv) and 8.44g iron (151.1 mmol, 5 equiv) were mixed in 100 mL acetic acid and 50 mL EtOAc and were stirred at rt overnight. The reaction mixture was filtered through a pad of Celite.(R).. The filtrate was concentrated in vacuo and neutralized with saturated Na2CO3 solution. The solution was extracted with EtOAc and the organic layer was washed with brine and concentrated in vacuo. The resulting crude material was purified by flash chromatography eluting with EtOAc/hexane (3:7) to give 3-Chloro-4-(pyridin-2-ylmethoxy)-phenylamine (3.2 g, 52percent) as a white solid. 1H-NMR (CDCl3) δ 5.18 (s, 2H), 6.50 (dd, IH), 6.76 (d, IH),. 6.80 (d, IH), 7.22 (m, IH), 7.64 (d, IH), 7.73 (td, IH), 8.55 (m, IH); LCMS RT = 0.89 min; [M+H]+ = 235.1.
52% With caesium carbonate; sodium iodide In acetonitrile at 60℃; for 5 h; 2-chloro-4-nitro phenol (10 g, 57.6 mmol, 1 equiv), 2-pycolyl chloride hydrogen chloride (9.45 g, 57.6 mmol, 1 equiv), cesium carbonate 41.3 (126.8 mmol, 2.2 equiv) and sodium iodide (8.64 g, 57.6 mmol, 1 equiv) were suspended in 200 mL acetonitrile. The reaction mixture was stirred at 60° C. for 5 h. The resulted suspension was filtered and washed with water (400 mL), yielding 2-(2-chloro-4-nitro-phenoxymethyl)-pyridine (8 g, 52percent) as a red solid.
52% With caesium carbonate; sodium iodide In acetonitrile at 60℃; for 5 h; 2-Chloro-4-nitro phenol 10 g (57.6 mmol, 1 eq), 2-(chloromethyl)pyridine hydrogen chloride 9.45 g (57.6 mmol, 1 equiv), cesium carbonate (41.3 g, 126.8 mmol, 2.2 equiv) and sodium iodide 8.64 g (57.6 mmol, 1 equiv) were suspended in 200 mL acetonitrile. The reaction mixture was stirred at 60 0C for 5 h. The resulted suspension was filtered and washed with 400 mL water, yielding 2-(2-chloro-4-nitro-phenoxymethyl)-pyridine (8 g,52percent) as a red solid.

Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 11, p. 3090 - 3104
[2] Patent: US2016/214964, 2016, A1, . Location in patent: Paragraph 0138
[3] Patent: WO2005/10008, 2005, A1, . Location in patent: Page/Page column 114-115
[4] Patent: WO2006/23843, 2006, A2, . Location in patent: Page/Page column 64
[5] Patent: US2010/298297, 2010, A1, . Location in patent: Page/Page column 14
[6] Patent: WO2006/55268, 2006, A2, . Location in patent: Page/Page column 32
[7] Research on Chemical Intermediates, 2013, vol. 39, # 7, p. 3105 - 3110
[8] Patent: EP3181553, 2017, A1, . Location in patent: Paragraph 0209; 0210
[9] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 316 - 336
  • 21
  • [ 4377-33-7 ]
  • [ 619-08-9 ]
  • [ 179687-79-7 ]
YieldReaction ConditionsOperation in experiment
52% With hydrogenchloride; caesium carbonate; sodium iodide In acetonitrile at 60℃; for 5 h; Example 71; 4-f [3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino) [1]benzothieno[2,3-d] pyrimidin-7-ol; Step 1. Preparation of 3-Chloro-4-(pyridin-2-ylmethoxy)-phenylamine; EPO <DP n="84"/> 2-chloro-4-nitro phenol (10 g, 57.6 mmol, 1 equiv), 2-pycolyl chloride hydrogen chloride (9.45 g, 57.6 mmol, 1 equiv) cesium carbonate 41.3 (126.8 mmol, 2.2 equiv) and sodium iodide (8.64 g, 57.6 mmol, 1 equiv) were suspended in 200 mL acetonitrile. The reaction mixture was stirred at 60°C for 5h. The resulted suspension was filtered and washed with water (400 mL), yielding 2-(2-chloro-4- nitro-phenoxymethyl)-pyridine (8 g, 52percent) as a red solid.2-(2-chloro-4-nitro-phenoxyrnethyl)-pyridine (8 g, 30.2mmol, 1 equiv) and iron (8.44 g, 151.1 mmol, 5 equiv) were mixed in acetic acid (100 mL ) and EtOAc (50 mL ) and were stirred at rt overnight. The reaction mixture was filtered through a pad of Celite.(R).. The filtrate was concentrated in vacuo and neutralized with saturated Na2CO3 solution. The solution was extracted with EtOAc and the organic layer was washed with brine and concentrated in vacuo. The resulting crude material was purified by flash chromatography eluting with EtOAc/hexane (3:7) to give 3-Chloro- 4-(pyridin-2-ylmethoxy)-phenylamine (3.2 g, 52percent) as a white solid. 1H-NMR (CDCl3) δ 5.18 (s, 2H), 6.50 (dd, 1H), 6.76 (d, 1H),. 6.80 (d, 1H), 7.22 (m, 1H), 7.64 (d, 1H), 7.73 (td, 1H), 8.55 (m, 1H); LCMS RT = 0.89 min, [M+H]+ = 235.1.
Reference: [1] Patent: WO2006/44524, 2006, A1, . Location in patent: Page/Page column 82-83
[2] European Journal of Medicinal Chemistry, 2018, vol. 144, p. 330 - 348
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 619-08-9 ]

Neratinib Related Intermediates

Chemical Structure| 848133-75-5

[ 848133-75-5 ]

N-(3-Cyano-7-ethoxy-4-hydroxyquinolin-6-yl)acetamide

Chemical Structure| 848133-76-6

[ 848133-76-6 ]

N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide

Chemical Structure| 94-05-3

[ 94-05-3 ]

Ethyl (ethoxymethylene)cyanoacetate

Chemical Structure| 179687-79-7

[ 179687-79-7 ]

2-((2-Chloro-4-nitrophenoxy)methyl)pyridine

Chemical Structure| 524955-09-7

[ 524955-09-7 ]

3-Chloro-4-(pyridin-2-ylmethoxy)aniline